|
|
Post by u1682002 on Apr 19, 2017 23:43:12 GMT -5
Matt mentioned during one of the conference calls that Mnkd was discussing with one of the countries to sell large quantity of Afrezza with little profit or no profit. Not sure such a talk still under way. Giving current financial situation, this could be the best option for mnkd: generate some cash flow using current inventory.
Anyone else on this remember this?
|
|
|
|
Post by lakon on Apr 20, 2017 9:40:15 GMT -5
Matt mentioned during one of the conference calls that Mnkd was discussing with one of the countries to sell large quantity of Afrezza with little profit or no profit. Not sure such a talk still under way. Giving current financial situation, this could be the best option for mnkd: generate some cash flow using current inventory. Anyone else on this remember this? I don't recall it exactly like you wrote, but there was talk about selling directly into other countries, especially in the Middle East, such as to hospitals and such. The talk was a while ago. I don't recall discussions about profit or lack thereof. I'd assume that when we lost the Don [Al], we lost our political connections in the region. |
|
|
|
Post by Cowgirl on Apr 20, 2017 10:12:31 GMT -5
...there was lots of talk....all technosphere applications, partners, int'l partners, Al Mann legacy. This has become an absolute disaster because they always wanted to go it alone...but it put us in this hole spiraling downward. They need to beg someone to buy them but who would buy them if they are only selling 200 prescriptions a week and burn 10 Mil a month and HAVE to undertake a long term safety study costing maybe hundreds of millions. Someone will be requiring that mannkind PAY THEM!
|
|
|
|
Post by cjm18 on Apr 20, 2017 10:15:40 GMT -5
...there was lots of talk....all technosphere applications, partners, int'l partners, Al Mann legacy. This has become an absolute disaster because they always wanted to go it alone...but it put us in this hole spiraling downward. They need to beg someone to buy them but who would buy them if they are only selling 200 prescriptions a week and burn 10 Mil a month and HAVE to undertake a long term safety study costing maybe hundreds of millions. Someone will be requiring that mannkind PAY THEM! long term safety study costs 100s of millions? |
|
|
|
Post by dg1111 on Apr 20, 2017 11:52:22 GMT -5
I think based on yesterday's deal with Deerfield, it's safe to assume that there is not an imminent deal that will inject us with cash.
|
|
|
|
Post by silentknight on Apr 20, 2017 12:09:06 GMT -5
I think based on yesterday's deal with Deerfield, it's safe to assume that there is not an imminent deal that will inject us with cash. Agreed. But the better question is why would anyone have expected a deal in the first place when MNKD can't sell more than 300 scripts per week? Why would an international partner want to fork over money to sell a product that that's a commercial bust? Companies don't partner for flops. They partner for success and MNKD can't seem to prove that Afrezza is anything other than a huge drain on their finances. Matt may have spoken about partnerships but I suspect that's just more of his wishful thinking and smoke to try and paint the picture to be rosier than it actually is. There are no partners or we would have known about it by now, and there won't be any in all liklihood until MNKD sells the drug. It's becoming clearer by the week that they are unable to do that. Empty promises all around. No sales when they expected them, and R/S and dilution when they supposedly aren't considering them. In my opinion, Matt's been walking a very dangerous line with his statements recently. A good lawyer could probably make the case that by saying one thing and doing the opposite, he's violating his fiduciary duties and misleading shareholders. |
|
|
|
Post by u1682002 on Apr 20, 2017 12:32:14 GMT -5
Well, actually I think there are people or companies are still willing to invest or buy companies with potential even its current sales are horrible. MNKD management should look east more these days instead of continuously dealing with players like Deerfield. But I am afraid Matt/Mike or MNKD board have too much pride to do so.
|
|
|
|
Post by mnholdem on Apr 20, 2017 13:26:36 GMT -5
One very important consideration related to international sales is that most countries do not allow DTC marketing and so the marketing restrictions that are imposed in the USA are not a major issue. International government healthcare/drug agencies decide what drugs are approved for sale and how the drug information is disseminated.
Even with its current non-inferiority label, Afrezza remains the world's only available inhaled insulin. Also important is that there are countries where needle-phobia exists and an option like Afrezza may be rapidly adopted by physicians there.
 |
|
|
|
Post by radgray68 on Apr 20, 2017 15:04:56 GMT -5
Question: Can Mannkind strike an international deal? Answer : Apparently not.
We are 6 weeks short of 3 years since approval of the worlds ONLY needle-free option in diabetes. Still not even a single pallet has been shipped over seas. That is a big head scratcher for me. I have been careful not to join the management bashers that swarm the blogs and chat rooms, but at the 3 year mark, I'm starting to wonder if someone else could get this done. Whatever the reasons for holding back on international sales in the past, it doesn't work for me anymore. I hope something is actually planned or implemented soon. It just doesn't make any sense not to try.
License to all big international sales organizations for one year. The one who sells the most, gets the global contract. Take your marks, get set, GO!!!!!
I can hear it now. "Oh that's not possible, It's amateurish, Never been done....blah, blah, blah." I don't care what is thought of it if it gets the product out to the populations that need them. Al wanted it out there, I want it out there period. |
|
|
|
Post by careful2invest on Apr 20, 2017 16:29:21 GMT -5
One very important consideration related to international sales is that most countries do not allow DTC marketing and so the marketing restrictions that are impose in the USA are often irrelevant. International government healthcare/drug agencies decide what drugs are approved for sale and how the drug information is disseminated.
Even with its current non-inferiority label, Afrezza remains the world's only available inhaled insulin. Frankly, there are certain countries where needle-phobia exists and an option like Afrezza may be rapidly adopted by physicians there.
In addition, opening sales to the world market would limit the control that BP (and the rest of the crooks) have on the market here in the USA. But this lack of addressing so many obvious untapped markets and leads by MNKD just does not make sense! MNKD's blunders are inexcusable in a field where professionalism and strategical prowess are a must! For so long, I, as well as many others kept saying that they (MNKD) have to have something bigger in the works due to the repeated, blatant actions (or non actions) that we have witnessed over the last three years. But unfortunately, to our surprise, they did not! Someone or some company has to realize the benefits and potential of AFREZZA and have the money and the stones to see it through. At this stage of the game, We can only hope! |
|
|
|
Post by kc on Apr 20, 2017 17:01:04 GMT -5
Question: Can Mannkind strike an international deal? Answer : Apparently not.
We are 6 weeks short of 3 years since approval of the worlds ONLY needle-free option in diabetes. Still not even a single pallet has been shipped over seas. That is a big head scratcher for me. I have been careful not to join the management bashers that swarm the blogs and chat rooms, but at the 3 year mark, I'm starting to wonder if someone else could get this done. Whatever the reasons for holding back on international sales in the past, it doesn't work for me anymore. I hope something is actually planned or implemented soon. It just doesn't make any sense not to try.
License to all big international sales organizations for one year. The one who sells the most, gets the global contract. Take your marks, get set, GO!!!!!
I can hear it now. "Oh that's not possible, It's amateurish, Never been done....blah, blah, blah." I don't care what is thought of it if it gets the product out to the populations that need them. Al wanted it out there, I want it out there period. |
|
|
|
Post by Cowgirl on Apr 21, 2017 8:56:00 GMT -5
You can't have a trained CPA and a Pharamacist running a public company. You need people who know how to run and finance a business. All this is is a good college try. They've been schooled on how not to run and finance a company - we've all schooled on believing there were potential partners, int'l deals, techno indications.
|
|
|
|
Post by Cowgirl on Apr 21, 2017 8:59:15 GMT -5
CJM 18...think about a 5000+ plus person study - running for years and years. How much do you think that costs. It will be huge.
This is also a hang up on why no one will buy Mannkind. One, Mann Foundation appears to be ok trying to the end and they have controlling stake. 100+ in debt outstanding. and liability of long term safety trials.
300 Scripts a week doesn't pay for that...someone will want mannkind to PAY THEM to take on those liabilities...
|
|
|
|
Post by jay1ajay1a on Apr 21, 2017 11:11:35 GMT -5
They do have the billon in losses, that would off set some of the costs.
But I don't think it will happen. I am hoping for something to go MNKD's way, but we don't have a Tom Brady on the team.
|
|
|
|
Post by dreamboatcruise on Apr 21, 2017 12:18:52 GMT -5
Question: Can Mannkind strike an international deal? Answer : Apparently not.
We are 6 weeks short of 3 years since approval of the worlds ONLY needle-free option in diabetes. Still not even a single pallet has been shipped over seas. That is a big head scratcher for me. I have been careful not to join the management bashers that swarm the blogs and chat rooms, but at the 3 year mark, I'm starting to wonder if someone else could get this done. Whatever the reasons for holding back on international sales in the past, it doesn't work for me anymore. I hope something is actually planned or implemented soon. It just doesn't make any sense not to try.
License to all big international sales organizations for one year. The one who sells the most, gets the global contract. Take your marks, get set, GO!!!!!
I can hear it now. "Oh that's not possible, It's amateurish, Never been done....blah, blah, blah." I don't care what is thought of it if it gets the product out to the populations that need them. Al wanted it out there, I want it out there period. I constantly get the feeling people don't understand what sales reps do within the pharma world. They aren't going around and knocking on doors asking patients to buy a box. The way it really happens, calling on doctors to try to convince them Afrezza is a good treatment, how would scripts be counted if there were multiple competing sales reps calling on the same doctors? |
|
